These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 5400154)

  • 1. [Glycoprotein metabolism in galactosamine-induced hepatitis].
    Reutter W; Keppler D; Lesch R; Decker K
    Verh Dtsch Ges Inn Med; 1969; 75():363-5. PubMed ID: 5400154
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on the mechanism of galactosamine-induced hepatitis].
    Keppler D; Reutter W; Lesch R; Decker K
    Verh Dtsch Ges Inn Med; 1969; 75():361-3. PubMed ID: 5400153
    [No Abstract]   [Full Text] [Related]  

  • 3. [Intravenous and oral galactose loading of rats suffering from galactosamine hepatitis and ANIT-cholestasis; comparison of the kinetics in vivo and the galactose metabolism in the liver in vitro (author's transl)].
    Richter E; Hofstetter GJ; Seifert H
    Z Gastroenterol; 1979 Oct; 17(10):713-21. PubMed ID: 524947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Morphological picture of galactosamine lesions of the rat liver].
    Lesch R; Reutter W; Keppler W; Decker K
    Verh Dtsch Ges Inn Med; 1969; 75():358-61. PubMed ID: 5400152
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of essential phospholipids on the galactosamine hepatitis in rats].
    Petzold H; Titlbach O
    Cesk Gastroenterol Vyz; 1974 Apr; 28(3):178-80. PubMed ID: 4447983
    [No Abstract]   [Full Text] [Related]  

  • 6. Bilirubin metabolism in experimental liver injury.
    Garay EA; Campa JP
    J Lab Clin Med; 1968 Oct; 72(4):582-91. PubMed ID: 5677306
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prevention of galactosamine hepatitis using administration of D-galactose: significance of temporally limited UDP-galactose deficit for the induction of galactosamine hepatitis].
    Bauer C; Reutter W; Bachmann W; Lesch R
    Hoppe Seylers Z Physiol Chem; 1972 Oct; 353(10):1502. PubMed ID: 4649767
    [No Abstract]   [Full Text] [Related]  

  • 8. [Primary and secondary liver response to D-galactosamine administration in galactosamine hepatitis].
    Reutter W; Bauer C; Bachman W; Lesch R
    Verh Dtsch Ges Inn Med; 1973; 79():927-30. PubMed ID: 4790045
    [No Abstract]   [Full Text] [Related]  

  • 9. [Glycoproteins in toxic and viral lesions of the liver].
    Dobrotina NA; Travina NM
    Vopr Med Khim; 1981; 27(6):800-4. PubMed ID: 7336655
    [No Abstract]   [Full Text] [Related]  

  • 10. Liver parenchymal cell injury. V. Relationships between patterns of chloromethane-C 14 incorporation into constituents of liver in vivo and cellular injury.
    Reynolds ES; Yee AG
    Lab Invest; 1967 Apr; 16(4):591-603. PubMed ID: 4290484
    [No Abstract]   [Full Text] [Related]  

  • 11. [Significance of enzyme activity in pyrimidine biosynthesis for the development of galactosamine liver lesions].
    Pausch J; Keppler D; Decker K
    Verh Dtsch Ges Inn Med; 1972; 78():1375-7. PubMed ID: 4665550
    [No Abstract]   [Full Text] [Related]  

  • 12. [Relations between phospholipid composition of plasma and liver microsomes in experimental cholestasis and hepatitis].
    Gallenkamp H; Brachtel D; Richter E
    Verh Dtsch Ges Inn Med; 1973; 79():930-3. PubMed ID: 4790046
    [No Abstract]   [Full Text] [Related]  

  • 13. Metabolism of radioactive zinc in the liver damaged with carbon tetrachloride. II. Autoradiographic studies.
    Majewski C; Wysocki K; Owczarek L; Kurnatowska A; Górski S
    Acta Med Pol; 1966; 7(3):245-52. PubMed ID: 5918728
    [No Abstract]   [Full Text] [Related]  

  • 14. The metabolism of radioactive zinc in the liver of rats damaged by a single administration of carbon tetrachloride. I. Radioisotope studies.
    Wysocki K; Owczarek L; Fenrych W; Gorski S; Majewski C
    Acta Med Pol; 1966; 7(1):97-102. PubMed ID: 5945725
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the mechanism of inhibition of protein synthesis in rat liver 30 minutes after CCl-4 damage].
    Richter G; Michel S
    Acta Biol Med Ger; 1965; 15(6):667-79. PubMed ID: 5884595
    [No Abstract]   [Full Text] [Related]  

  • 16. [Tyrosine metabolism in experimental toxic hepatitis].
    Kontsevaia NG
    Vopr Med Khim; 1971; 17(1):3-6. PubMed ID: 5555144
    [No Abstract]   [Full Text] [Related]  

  • 17. Metabolism of radioactive zinc in the liver damaged with carbon tetrachloride. 3. Studies at the subcellular level.
    Wysocki K; Hansz J; Owczarek L; Fenrych W; Górski S; Majewski C
    Acta Med Pol; 1966; 7(3):253-6. PubMed ID: 5918729
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of liver injury and of induced inflammation on the serum glycoprotein level.
    Fehér J; Jakab L; Takács L
    Acta Med Acad Sci Hung; 1970; 27(1):57-63. PubMed ID: 5454559
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of methandrostenolone on the glycogen content of the liver and several pathochemical changes in lipid metabolism in experimental chronic toxic hepatitis].
    Abdullaev NKh
    Probl Endokrinol Gormonoter; 1966; 12(4):106-10. PubMed ID: 6002008
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of methandrostenolone on protein metabolism in the liver and protein fractions of the blood serum in experimental hepatitis].
    Abdullaev NKh
    Vopr Med Khim; 1966; 12(6):627-32. PubMed ID: 4174974
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.